These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


171 related items for PubMed ID: 3874558

  • 1. Corticotropin-releasing factor, sauvagine, and urotensin I: effects on blood flow.
    Lenz HJ, Fisher LA, Vale WW, Brown MR.
    Am J Physiol; 1985 Jul; 249(1 Pt 2):R85-90. PubMed ID: 3874558
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Comparison of the biologic actions of corticotropin-releasing factor and sauvagine.
    Brown MR, Fisher LA, Spiess J, Rivier J, Rivier C, Vale W.
    Regul Pept; 1982 Jul; 4(2):107-14. PubMed ID: 6289384
    [Abstract] [Full Text] [Related]

  • 4. CRF-like effects of sauvagine and urotensin I on synaptosomal tyrosine hydroxylase activity of mouse striatum.
    Onali P, Olianas MC.
    Brain Res; 1990 Sep 03; 526(2):181-5. PubMed ID: 1979515
    [Abstract] [Full Text] [Related]

  • 5. Corticotropin releasing factor-like peptides produce selective dilatation of the dog mesenteric circulation.
    MacCannell KL, Hamilton PL, Lederis K, Newton CA, Rivier J.
    Gastroenterology; 1984 Jul 03; 87(1):94-102. PubMed ID: 6327456
    [Abstract] [Full Text] [Related]

  • 6. Effects of corticotropin releasing factor and sauvagine on social behavior of isolated mice.
    Mele A, Cabib S, Oliverio A, Melchiorri P, Puglisi-Allegra S.
    Peptides; 1987 Jul 03; 8(5):935-8. PubMed ID: 3501578
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Use of selective mesenteric vasodilator peptides in experimental nonocclusive mesenteric ischemia in the dog.
    MacCannell KL, Newton CA, Lederis K, Rivier J, Tiffany M.
    Gastroenterology; 1986 Mar 03; 90(3):669-76. PubMed ID: 3484710
    [Abstract] [Full Text] [Related]

  • 10. Central nervous system effects of corticotropin releasing factor in the dog.
    Brown MR, Fisher LA.
    Brain Res; 1983 Nov 28; 280(1):75-9. PubMed ID: 6606481
    [Abstract] [Full Text] [Related]

  • 11. CRF initiates biological actions within the brain that are observed in response to stress.
    Lenz HJ, Raedler A, Greten H, Brown MR.
    Am J Physiol; 1987 Jan 28; 252(1 Pt 2):R34-9. PubMed ID: 3544874
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Urotensin I-like immunoreactivity in the central nervous system of Aplysia californica.
    Gonzalez GC, Martinez-Padron M, Ko D, Lukowiak K, Lederis K.
    Peptides; 1991 Jan 28; 12(4):787-93. PubMed ID: 1788142
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Corticotropin-releasing factor receptor antagonist: effects on the autonomic nervous system and cardiovascular function.
    Brown MR, Gray TS, Fisher LA.
    Regul Pept; 1986 Dec 30; 16(3-4):321-9. PubMed ID: 3031745
    [Abstract] [Full Text] [Related]

  • 20. Sauvagine-like and corticotropin-releasing factor-like immunoreactivity in the brain of the bullfrog (Rana catesbeiana).
    Gonzalez GC, Lederis K.
    Cell Tissue Res; 1988 Jul 30; 253(1):29-37. PubMed ID: 3262016
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.